mefloquine is used to both prevent and treat certain forms of malaria it is typically taken for one to two weeks before entering an area with malaria if a person becomes ill with malaria despite prophylaxis with mefloquine , the use of halofantrine and quinine for treatment may be ineffective mefloquine is used as a treatment for chloroquine-sensitive or resistant plasmodium falciparum malaria , and is deemed a reasonable alternative for uncomplicated chloroquine-resistant plasmodium vivax malaria it is one of several drugs recommended by the united states ' centers for disease control and prevention vivax malaria should be treated with a second drug that is effective for the liver phase , such as primaquine common side effects include vomiting , diarrhea , headaches , and a rash severe side effects requiring hospitalization are rare , but include mental health problems such as depression , hallucinations , anxiety and neurological side effects such as ataxia , seizures , and tinnitus mefloquine is therefore not recommended in people with a history of psychiatric disorders or epilepsy in 2013 the fda stated '' neurologic side effects can occur at any time during drug use , and can last for months to years after the drug is stopped or can be permanent combining mefloquine with other drugs that cause similar effects , such as quinine or quinidine , can increase these effects mefloquine is contraindicated in those with a previous history of seizures or a recent history of psychiatric disorders available data suggests that mefloquine is safe and effective for use by pregnant women during all trimesters of pregnancy , and it is widely used for this indication compared to other malaria chemoprophylaxis regimens , however , mefloqinone may produce more side effects in non-pregnant travelers the mean elimination plasma half-life of mefloquine is between two and four weeks canadian soldiers who took mefloquine when deployed overseas have claimed they have been left with ongoing mental health problems 